| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 629 companies in the Biotechnology industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | AXSM Axsome Therapeutics, Inc. | Jeffs Roger66 | Director | Sell | 572 | $247.65 | $141,655.80 | -0.5% | - | - | |
| Jun 11, 2026 | QURE Uniqure N.V. | Meek David D.46 | Director | Sell | 1,993 | $27.06 | $53,930.58 | -4.8% | - | - | |
| Jun 11, 2026 | HOWL Werewolf Therapeutics, Inc. | Ra Capital Management, L.P.53 | 10% Owner | Sell | 678,226 | $0.37 | $253,568.65 | -3.9% | - | - | |
| Jun 11, 2026 | ARTV Artiva Biotherapeutics, Inc. | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 1,027,722 | $7.44 | $7,650,148.29 | +2.2% | - | - | |
| Jun 10, 2026 | ADTX Aditxt, Inc. | Hrt Financial LP45 | 10% Owner | Buy | 2,148,823 | $0.04 | $83,532.43 | +2,543% | - | - | |
| Jun 10, 2026 | AXSM Axsome Therapeutics, Inc. | Coleman Mark | Director | Sell | 643 | $249.00 | $160,107.00 | -2.1% | - | - | |
| Jun 10, 2026 | AXSM Axsome Therapeutics, Inc. | Mahony Susan | Director | Sell | 600 | $241.70 | $145,017.00 | -23.5% | - | - | |
| Jun 9, 2026 | NUVB Nuvation Bio Inc. | Mashal Robert | Director | Buy | 25,000 | $4.73 | $118,250.00 | +12.5% | - | - | |
| Jun 9, 2026 | ADTX Aditxt, Inc. | Gong Sandie | 10% Owner | Sell | 100,000 | $0.07 | $6,880.00 | -100% | - | - | |
| Jun 9, 2026 | ADTX Aditxt, Inc. | Hrt Financial LP45 | 10% Owner | Sell | 878,659 | $0.03 | $28,995.75 | -73.6% | - | - | |
| Jun 8, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Bjerkholt Eric71 | Chief Financial Officer | Sell | 5,000 | $93.82 | $469,077.01 | -3.5% | - | - | |
| Jun 8, 2026 | URGN Urogen Pharma Ltd. | Schoenberg Mark60 | Chief Medical Officer | Sell | 5,222 | $27.30 | $142,560.60 | -3.6% | - | - | |
| Jun 8, 2026 | GUTS Fractyl Health, Inc. | Smith Weber Lara | Chief Financial Officer | Buy | 20,000 | $0.69 | $13,708.00 | New | - | - | |
| Jun 8, 2026 | HOWL Werewolf Therapeutics, Inc. | Evnin Luke55 | Director | Sell | 105,565 | $0.41 | $43,028.88 | -7.6% | - | - | |
| Jun 5, 2026 | MGX Metagenomi Therapeutics, Inc. | Wapnick Pamela69 | Chief Financial Officer | Sell | 2,884 | $1.30 | $3,746.32 | -1.4% | - | - | |
| Jun 5, 2026 | EQ Equillium, Inc. | Zedelmayer Christine63 | Sr. Vice President And COO | Sell | 14,584 | $2.93 | $42,736.95 | -18.9% | - | - | |
| Jun 5, 2026 | MGX Metagenomi Therapeutics, Inc. | Irish Jian64 | See Remarks | Sell | 3,737 | $1.30 | $4,854.36 | -1.0% | - | - | |
| Jun 5, 2026 | MGX Metagenomi Therapeutics, Inc. | Wein Matthew66 | See Remarks | Sell | 558 | $1.30 | $724.84 | -0.4% | - | - | |
| Jun 5, 2026 | EQ Equillium, Inc. | Connelly Stephen79 | President And CSO | Sell | 230,975 | $3.13 | $723,829.60 | -12.9% | - | - | |
| Jun 5, 2026 | ADTX Aditxt, Inc. | Hrt Financial LP45 | 10% Owner | Sell | 735,462 | $0.06 | $45,598.64 | -100% | - | - | |
| Jun 4, 2026 | PHVS Pharvaris N.V. | Nijdam Anna | Principal Accounting Officer | Sell | 2,670 | $30.87 | $82,425.04 | -5.5% | - | - | |
| Jun 4, 2026 | SMMT Summit Therapeutics Inc. | Duggan Robert W76 | Co-chief Executive Officer | Buy | 100,000 | $14.60 | $1,460,000.00 | +0.4% | - | - | |
| Jun 4, 2026 | INKT Mink Therapeutics, Inc. | Ryan Barbara | Director | Sell | 1,500 | $12.76 | $19,141.25 | -3.2% | - | - | |
| Jun 4, 2026 | KOD Kodiak Sciences Inc. | Borgeson John A.66 | Chief Financial Officer | Sell | 30,000 | $34.10 | $1,023,008.64 | -6.6% | - | - | |
| Jun 4, 2026 | ADTX Aditxt, Inc. | Hrt Financial LP45 | 10% Owner | Buy | 843,622 | $0.08 | $64,115.27 | -249.4% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.